Thoracic Imaging 2003 - Society of Thoracic Radiology
Thoracic Imaging 2003 - Society of Thoracic Radiology
Thoracic Imaging 2003 - Society of Thoracic Radiology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
curves (TDCs) are generated by manually tracing regions <strong>of</strong><br />
interest (ROIs) over lung segments showing flow-deficits. A<br />
ROI over the main pulmonary artery or the right ventricle can<br />
be used as input function. Regional pulmonary blood-flow in<br />
each segment can then be assessed according to the indicator<br />
dilution theory 73 74 using a basic flow equation 64, 69 where<br />
PBF / V = DPul / ÚC RC dt (PBF/V = pulmonary blood flow per<br />
unit volume <strong>of</strong> lung tissue; DPul = peak HU change during contrast<br />
injection; ÚC RC dt = area under a g variate-fit <strong>of</strong> a TDC <strong>of</strong><br />
the right side <strong>of</strong> the circulation).<br />
Advantages and Disadvantages <strong>of</strong> Functional EBCT Perfusion<br />
<strong>Imaging</strong> <strong>of</strong> the Lung:<br />
Once a suspicion <strong>of</strong> pulmonary embolism arises, crucial<br />
questions need to be answered: Is it indeed PE that causes the<br />
patient’s symptoms, or are there other reasons for the patient’s<br />
discomfort? If it is PE, where are the emboli located and how<br />
extensive is the disease? Does anticoagulation suffice, or are<br />
thrombolysis or invasive measures warranted? And are there<br />
conditions that prohibit thrombolysis? Where does the disease<br />
originate? Contrast enhanced CT provides high spatial resolution<br />
and allows the objective, non-invasive visualization <strong>of</strong> thoracic<br />
anatomy. Sources <strong>of</strong> chest pain other than PE can be identified.<br />
The location <strong>of</strong> pulmonary emboli and the extent <strong>of</strong> the<br />
disease can be assessed to determine the need for and feasibility<br />
<strong>of</strong> anticoagulation, thrombolysis or more invasive measures.<br />
However, to date, computed tomography has not permitted the<br />
functional evaluation <strong>of</strong> pulmonary microcirculation during pulmonary<br />
embolism. CT perfusion measurements as described in<br />
this chapter may represent a valuable adjunct to CT pulmonary<br />
angiography by providing both structural and functional information<br />
using the same modality. The well-established accuracy<br />
<strong>of</strong> CT for the depiction <strong>of</strong> emboli and thoracic anatomy is thus<br />
supplemented by an effective means to quantitatively assess the<br />
functional effect <strong>of</strong> thromboemboli on lung perfusion. This way,<br />
a comprehensive diagnosis is feasible within few minutes, without<br />
having to subject a patient to multiple expensive and timeconsuming<br />
tests requiring transportation and advanced logistics.<br />
In a recent study 32 we were able to show that EBCT can successfully<br />
be used for the functional analysis <strong>of</strong> pulmonary blood<br />
flow and therefore allows to differentiate between segments<br />
with normal and reduced capillary perfusion. This allows to<br />
estimate the percentage <strong>of</strong> lung parenchyma with impaired<br />
microcirculation. Thus, a decision whether anticoagulation or<br />
thrombolysis is warranted is facilitated. During the course <strong>of</strong><br />
treatment, the effect <strong>of</strong> therapy may be monitored by comparing<br />
pre- and post-therapy blood-flow values by repetitive scanning.<br />
Up to two thirds <strong>of</strong> patients with initially suspected PE receive<br />
other diagnoses including unknown malignancies or life-threatening<br />
conditions such as aortic rupture or dissection. By initially<br />
performing a contrast enhanced thin-slice volume study, the<br />
presence <strong>of</strong> pulmonary embolism can be verified and other or<br />
additional underlying diseases are readily recognized. The<br />
patient with previously unknown small-cell lung cancer in our<br />
patient group illustrates the importance <strong>of</strong> a thorough analysis<br />
<strong>of</strong> thoracic structure. A major limitation is that the 7.6 cm scan<br />
volume <strong>of</strong> the dynamic study does not cover the entire chest.<br />
The additional radiation dose for the dynamic study amounts to<br />
an effective dose equivalent <strong>of</strong> 7.2 mSv, which about equals the<br />
radiation exposure usually applied during nuclear scanning 75 .<br />
While there is good correlation between volume and functional<br />
scans for the detection <strong>of</strong> segmental emboli, a potential<br />
limitation <strong>of</strong> this technique arises from partial occlusion <strong>of</strong> vessels<br />
with maintained blood flow on a capillary level despite <strong>of</strong><br />
the presence <strong>of</strong> thrombi. Such findings may be regarded as<br />
“false negative” results. However, valuable information can be<br />
gained by assessing the actual effect <strong>of</strong> small emboli on lung<br />
microcirculation. Completely or partially maintained perfusion<br />
despite <strong>of</strong> the presence <strong>of</strong> emboli revealed by functional scanning<br />
may influence the decision whether or not to start thrombolytic<br />
therapy in a patient, the latter carrying a small but definite<br />
risk 59 60 . Thus the quantitative assessment <strong>of</strong> the effect <strong>of</strong><br />
PE on tissue perfusion may bear more important information for<br />
patient management than the direct visualization <strong>of</strong> emboli by<br />
CT angiography alone. Non-occluding emboli are also a wellknown<br />
problem in lung scintigraphy, where even extensive central<br />
emboli frequently go undiagnosed if they are only partially<br />
occluding and do not cause localized perfusion defects. Similar<br />
pitfalls can be avoided by the combined use <strong>of</strong> both CT angiography<br />
and CT perfusion measurement for a comprehensive diagnosis.<br />
Our model for the assessment <strong>of</strong> pulmonary blood flow in<br />
patients with suspected PE has been previously described 64 69<br />
73 . However, numerous different models have been developed<br />
in the past for the derivation <strong>of</strong> different blood flow parameters<br />
from non-invasive imaging modalities.<br />
Functional Multidetector-Row CT <strong>Imaging</strong> <strong>of</strong> Lung Perfusion:<br />
Dedicated image processing tools are currently being developed<br />
for use with high-resolution Multidetector-row CT. Based<br />
on EBCT experiences we currently pursue several approaches to<br />
non-invasively visualize blood-flow parameters in the lung with<br />
a dedicated s<strong>of</strong>tware platform (LungLab, Siemens).<br />
LungLab is an image processing tool for diagnosis <strong>of</strong> pulmonary<br />
embolism using high-resolution Multidetector-row CT<br />
protocols. For visualization <strong>of</strong> lung attenuation “Perfusion<br />
weighted display” allows color encoded display <strong>of</strong> lung<br />
parenchyma enhancement. This kind <strong>of</strong> display is generated by<br />
acquiring a high resolution Multidetector-row CT data set <strong>of</strong> the<br />
entire thorax with 500 msec gantry rotation, pitch <strong>of</strong> 6 at 120<br />
kV and 120 mAs. Contrast enhancement is achieved with a<br />
sharp (5 cc/s) bolus <strong>of</strong> 120 cc low-viscosity, non-ionic contrast<br />
material with 16 s delay via a cubital vein. Images are reconstructed<br />
with 1-mm sections with a s<strong>of</strong>t body kernel. The lung<br />
parenchyma is segmented from the enhanced thin slice reconstructions<br />
using threshold based contour finding to extract the<br />
lung volume and HU range selection to suppress major vascular<br />
structures. The segmented images are low pass filtered with an<br />
adaptive 3D filter. The filter can be selected out <strong>of</strong> a range <strong>of</strong><br />
dedicated image filters. The resulting images are interactively<br />
mapped on a spectral color scale in order to optimally display<br />
differences in enhancement. Additional overlay <strong>of</strong> the parenchymal<br />
color map onto the original CT-image is used to enhance<br />
visualization <strong>of</strong> spatial relationships. Due to the isotropic nature<br />
<strong>of</strong> high resolution Multidetector-row CT data set, color-coded<br />
images can be viewed in arbitrary imaging planes. This allows<br />
for semi-quantitative evaluation <strong>of</strong> blood flow in the lung<br />
parenchyma. We anticipate these methods to evolve in a valuable<br />
adjunct to CT pulmonary angiography by providing both<br />
structural and functional information using the same modality.<br />
The well-established accuracy <strong>of</strong> CT for the depiction <strong>of</strong> emboli<br />
and thoracic anatomy is thus supplemented by an effective<br />
means to quantitatively assess the functional effect <strong>of</strong> thromboemboli<br />
on lung perfusion. This way, a comprehensive diagnosis<br />
is feasible within few minutes, without having to subject a<br />
patient to multiple expensive and time-consuming tests requiring<br />
transportation and advanced logistics.<br />
Problems and Limitations <strong>of</strong> Computed Tomography for PE<br />
Diagnosis<br />
Contrast Media Injection and Artifacts:<br />
Despite advances in CT technology, there are still several<br />
factors that can render CT pulmonary angiography inconclusive.<br />
The most common reasons for non-diagnostic CT studies are<br />
poor contrast opacification <strong>of</strong> pulmonary vessels, patient motion<br />
and increased image noise due to excessive patient obesity.<br />
The advent <strong>of</strong> multidetector-row CT necessitates an exten-<br />
121<br />
MONDAY